Press Release

View all news

Incyte to Present at Upcoming Investor Conference

August 23, 2022 at 8:00 AM EDT

WILMINGTON, Del.--(BUSINESS WIRE)--Aug. 23, 2022-- Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. (EDT) in New York.

The presentation will be webcast live and can be accessed at and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.

Catalina Loveman
+1 302 498 6171

Christine Chiou
+1 302 274 4773

Source: Incyte